8月4日早间，药明康德（603259.SH、02359.HK）A股盘中股价涨停，A股市值超过4200亿元；港股股价盘中也大涨超过11%，港股市值超过5300亿港元。 前一晚，药明康德发布的半年报显示：今年上半年，得益于多个客户产品取得的更大成功，以及公司独特的CRDMO（合同研究、开发与生产组织）业务模式和全球团队卓越的管理与执行，公司整体营业收入为288.97亿元，同比增长38.9%；归属于...
Source Link8月4日早间，药明康德（603259.SH、02359.HK）A股盘中股价涨停，A股市值超过4200亿元；港股股价盘中也大涨超过11%，港股市值超过5300亿港元。 前一晚，药明康德发布的半年报显示：今年上半年，得益于多个客户产品取得的更大成功，以及公司独特的CRDMO（合同研究、开发与生产组织）业务模式和全球团队卓越的管理与执行，公司整体营业收入为288.97亿元，同比增长38.9%；归属于...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.